BOSTON – Oct. 26, 2022 – Linda M. Ricci, a White Collar Defense & Special Investigations Practice shareholder in global law firm Greenberg Traurig, LLP’s Boston office, will moderate a roundtable discussion addressing business development strategies for white-collar women practitioners Oct. 26 at 4 p.m. at the Boston Bar Association, 16 Beacon Street, Boston, Massachusetts.
Ricci focuses on matters related to corporate compliance and internal investigations, government investigations, money laundering violations, criminal tax offenses, forfeiture, wire fraud, securities fraud, theft of public funds, obstruction of justice, insider trading, and health care fraud. She draws from more than 15 years of experience working for the U.S. Attorney’s Office for the District of Massachusetts, where she served as chief of the Narcotics and Money Laundering Unit and was a member of the Economic Crimes Unit.
Ricci also has experience handling internal investigations in a variety of industries, including the pharmaceutical industry, the medical device industry, the international vitamin industry, and the airline publication industry. She conducts internal investigations, handles grand jury matters, responds to regulatory and law enforcement requests, and provides legal advice to public and private corporations, boards of directors, special committees, and officers, and individuals.
Ricci is an active member of Greenberg Traurig’s Women’s Initiative, the firm’s Trial Practice, and the Women’s White Collar Defense Association Thought Leadership Committee.
About Greenberg Traurig’s White Collar Defense & Special Investigations Practice: Greenberg Traurig’s White Collar Defense & Special Investigations Practice defends companies and individuals in a wide range of criminal, civil and regulatory enforcement proceedings around the world. Our team of over 70 lawyers in the U.S., Europe, Latin America, and Asia Pacific are at the forefront of white collar defense, with representative experience involving alleged securities and commodities fraud, Foreign Corrupt Practices Act (FCPA) violations, health care/pharmaceutical fraud, environmental crimes, money laundering, financial services fraud, public corruption/campaign finance, tax corruption, defense contracting, and bankruptcy fraud.